View Agent
| Agent Info | |
| Agent: | apricoxib |
| Synonyms: | TG01,CS-706 |
| Drug Status For Certain Diseases: | Discontinued inphase II(Non-small-cell lung carcinoma ) |
| Classification: | a novel, potent, well-tolerated selective inhibitor of COX-2 with the advantage of daily administration and perhaps superior preclinical activity compared with celecoxib |
| Target: | Prostaglandin G/H synthase 2 |
| KEGG Pathway: | NA |
| Wiki Pathway: | Spinal Cord Injury Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis Integrated Pancreatic Cancer Pathway Selenium Micronutrient Network Eicosanoid Synthesis Aryl Hydrocarbon Receptor Prostaglandin Synthesis and Regulation Arachidonic acid metabolism (Wikipathways) |